Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Oct;52(4):531–535. doi: 10.1038/bjc.1985.224

Cyclic AMP binding proteins in human breast cancer.

W R Miller, R O Senbanjo, J Telford, D M Watson
PMCID: PMC1977260  PMID: 2998423

Abstract

The characteristics of a method for measuring cyclic AMP binding proteins in cytosols of human breast cancer are described. Using the assay, binding proteins were demonstrable in all of 100 tumour cytosols. Levels of binding in individual tumours varied from 0.8 to 15 pmol mg-1 cytosol protein (mean value 5 pmol mg-1 cytosol protein) and the dissociation constant ranged from 0.5 to 5.2 X 10(-8)M (mean 1.73 X 10(-8)M). Whilst replicate measurements within a single portion of tumour were reproducible (intra-assay coefficient of variation was between 4.5 and 7.8% and that for inter-assay variation was between 2.1 and 4.0%) there were often considerable differences in levels of binding proteins between different portions of the same tumour. Similar intra-tumour variations have been reported for other binding proteins and steroid receptors. The inter-relationships with such parameters may elucidate whether the differences are associated with variations in cellularity, cell type, or other specific factors.

Full text

PDF
531

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodwin J. S., Clair T., Cho-Chung Y. S. Relationship of hormone dependency to estrogen receptor and adenosine 3',5'-cyclic monophosphate-binding proteins in rat mammary tumors. J Natl Cancer Inst. 1980 Feb;64(2):395–398. doi: 10.1093/jnci/64.2.395. [DOI] [PubMed] [Google Scholar]
  2. Bodwin J. S., Hirayama P. H., Rego J. A., Cho-Chung Y. S. Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacologic doses of 17 beta-estradiol: cyclic adenosine 3',5'-monophosphate-mediated events. J Natl Cancer Inst. 1981 Feb;66(2):321–326. [PubMed] [Google Scholar]
  3. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  4. Cho-Chung Y. S. Antagonistic action between cyclic adenosine 3':5'-monophosphate and estrogen in rat mammary tumor growth control. Cancer Res. 1978 Nov;38(11 Pt 2):4071–4075. [PubMed] [Google Scholar]
  5. Cho-Chung Y. S., Bodwin J. S., Clair T. Cyclic AMP-binding proteins: inverse relationship with estrogen-receptors in hormone-dependent mammary tumor regression. Eur J Biochem. 1978 May;86(1):51–60. doi: 10.1111/j.1432-1033.1978.tb12283.x. [DOI] [PubMed] [Google Scholar]
  6. Cho-Chung Y. S., Clair T., Schwimmer M., Steinberg L., Rego J., Grantham F. Cyclic adenosine 3':5-monophosphate receptor proteins in hormone-dependent and -independent rat mammary tumors. Cancer Res. 1981 May;41(5):1840–1846. [PubMed] [Google Scholar]
  7. Cho-Chung Y. S. Hypothesis. Cyclic AMP and its receptor protein in tumor growth regulation in vivo. J Cyclic Nucleotide Res. 1980;6(3):163–177. [PubMed] [Google Scholar]
  8. Eppenberger U., Biedermann K., Handschin J. C., Fabbro D., Küng W., Huber P. R., Roos W. Cyclic AMP-dependent protein kinase type I and type II and cyclic AMP binding in human mammary tumors. Adv Cyclic Nucleotide Res. 1980;12:123–128. [PubMed] [Google Scholar]
  9. Hawkins R. A., Hill A., Freedman B., Gore S. M., Roberts M. M., Forrest A. P. Reproducibility of measurements of oestrogen-receptor concentration in breast cancer. Br J Cancer. 1977 Sep;36(3):355–361. doi: 10.1038/bjc.1977.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kvinnsland S., Ekanger R., Døskeland S. O., Thorsen T. Relationship of cyclic AMP binding capacity and estrogen receptor to hormone sensitivity in human breast cancer. Breast Cancer Res Treat. 1983;3(1):67–72. doi: 10.1007/BF01806235. [DOI] [PubMed] [Google Scholar]
  11. Silfverswärd C., Skoog L., Humla S., Gustafsson S. A., Nordenskjöld B. Intratumoral variation of cytoplasmic and nuclear estrogen receptor concentrations in human mammary carcinoma. Eur J Cancer. 1980 Jan;16(1):59–65. doi: 10.1016/0014-2964(80)90108-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES